ResMed Announces Participation in the Bank of America Global Healthcare Conference
ResMed (NYSE: RMD) announced that CEO Mick Farrell will participate in a fireside chat at the Bank of America Global Healthcare Conference on September 14, 2022, at 9:05 a.m. BST in London. This event will be accessible via a live webcast, with a replay available approximately three hours after the event until December 13, 2022. ResMed continues to innovate with digital health technologies and cloud-connected medical devices, aiming to enhance the quality of life for patients suffering from chronic diseases globally.
- Participation in a major healthcare conference could enhance visibility and engagement with investors.
- CEO's presence at significant events reflects leadership commitment and could positively influence investor sentiment.
- None.
SAN DIEGO, Sept. 07, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a fireside chat at the Bank of America Global Healthcare Conference on Wednesday, September 14, 2022, beginning at approximately 9:05 a.m. (British Summer Time) at the Bank of America Financial Centre in London.
More information about this event, including a live webcast, may be accessed by visiting http://investor.resmed.com. The webcast replay will be available approximately 3 hours after the live webcast ends and will be accessible through December 13, 2022.
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
| For investors Amy Wakeham +1 858.836.5000 investorrelations@resmed.com | For media Jayme Rubenstein +1 858.836.6798 news@resmed.com |
FAQ
When is the ResMed conference appearance?
What is the focus of ResMed's innovations?
How can I access the ResMed conference webcast?
What is the significance of the Bank of America Global Healthcare Conference for ResMed?
